CrushSCI.com
133.2Average days
133Median days
2Fastest days
345Longest days
3622025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

42 days

Clinical Image: B cell lymphoma mimicking myositis

Authors
Mariana Manoel Oku; Joanna C Dalland; Aikaterini Thanou; Margherita MiloneShow moreShow less
Affiliations
1. Department of Neurology Mayo Clinic Rochester Minnesota; 2. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota; 3. University of Oklahoma College of Medicine Oklahoma City OklahomaShow moreShow less
Source PDF DOI Publisher page
41 days

Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial

Authors
Joseph F. Merola; Cynthia E. Kartman; Peter Fischer; Philip Mease; Alan Kivitz; Naveed Sattar; Laura C. Coates; Daniel Aletaha; Luna Sun; Yurong Chen; Ketan Marulkar; Natalia Bello; Anabela Cardoso; Mark C. Genovese; Alexis OgdieShow moreShow less
Affiliations
1. Departments of Dermatology and Medicine, Division of Rheumatology, and O'Donnell School of Public Health University of Texas Southwestern Medical Center Dallas; 2. Eli Lilly and Company Indianapolis Indiana; 3. Providence Swedish Medical Center and University of Washington Seattle; 4. Altoona Center for Clinical Research Duncansville Pennsylvania; 5. School of Cardiovascular and Metabolic Health University of Glasgow Glasgow United Kingdom; 6. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences University of Oxford Oxford United Kingdom; 7. Division of Rheumatology, Department of Internal Medicine III Medical University of Vienna Vienna Austria; 8. Perelman School of Medicine University of Pennsylvania PhiladelphiaShow moreShow less
Source PDF DOI Publisher page
186 days

Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis

Authors
Hilde Jenssen Bjørkekjær; Cosimo Bruni; Kaspar Broch; Cathrine Brunborg; Patricia E. Carreira; Paolo Airò; Carmen Pilar Simeón‐Aznar; Marie‐Elise Truchetet; Alessandro Giollo; Alexandra Balbir‐Gurman; Mickael Martin; Christopher P. Denton; Armando Gabrielli; Francesco Del Galdo; Madelon C. Vonk; Håvard Fretheim; Helle Bitter; Øyvind Midtvedt; Arne K. Andreassen; Sverre Høie; Yoshiya Tanaka; Gabriela Riemekasten; Ulf Müller‐Ladner; Marco Matucci‐Cerinic; Ivan Castellví; Elise Siegert; Eric Hachulla; Øyvind Molberg; Oliver Distler; Anna‐Maria Hoffmann‐Vold; the European Scleroderma Trials and Research (EUSTAR) collaboratorsShow moreShow less
Affiliations
1. Department of Rheumatology Hospital of Southern Norway Kristiansand Norway; 2. Institute of Clinical Medicine University of Oslo Oslo Norway; 3. Department of Rheumatology University Hospital Zurich, University of Zurich Zurich Switzerland; 4. Department of Cardiology Oslo University Hospital, Rikshospitalet Oslo Norway; 5. Institute for Experimental Medical Research, KG Jebsen Center University of Oslo Oslo Norway; 6. Oslo Centre for Biostatistics and Epidemiology, Research Support Services Oslo University Hospital, Rikshospitalet Oslo Norway; 7. Department of Rheumatology University Hospital 12 de Octubre Madrid Spain; 8. Scleroderma Unit UOC Reumatologia ed Immunologia Clinica, Spedali Civili di Brescia Brescia Italy; 9. Systemic Autoimmune Diseases Unit, Department of Internal Medicine University Vall d'Hebron Hospital Barcelona Spain; 10. Rheumatology Department Bordeaux University Hospital Bordeaux France; 11. Rheumatology Unit, Department of Medicine University of Verona Verona Italy; 12. Rheumatology Unit, Department of Medicine – DIMED Padua University Hospital Padova Italy; 13. Rheumatology Institute, Rambam Health Care Campus, Rappaport Faculty of Medicine Technion – Institute of Technology Haifa Israel; 14. Department of Internal Medicine Poitiers University Hospital Poitiers France; 15. Royal Free Hospital, Centre for Rheumatology and Connective Tissue Diseases, Division of Medicine University College London London United Kingdom; 16. Fondazione di Medicina Molecolare e Terapia Cellulare Università Politecnica delle Marche Ancona Italy; 17. Hiller Research Center University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf Germany; 18. Leeds Institute of Rheumatic and Musculoskeletal Medicine Leeds United Kingdom; 19. Leeds Biomedical Research Centre, National Institute for Health and Care Research Leeds Teaching Hospitals Trust Leeds United Kingdom; 20. Department of Rheumatology Radboud Universiteit Nijmegen the Netherlands; 21. Lillehammer Hospital for Rheumatic Diseases Lillehammer Norway; 22. Department of Rheumatology Oslo University Hospital, Rikshospitalet Oslo Norway; 23. Department of Cardiology Hospital of Southern Norway Arendal Norway; 24. ProCardio Center for Innovation, Clinic of Heart, Lung and Vascular Diseases Oslo University Hospital, Rikshospitalet Oslo Norway; 25. First Department of Internal Medicine University of Occupational and Environmental Health Kitakyushu Japan; 26. Department of Rheumatology and Clinical Immunology University of Lübeck Lübeck Germany; 27. Department of Rheumatology and Clinical Immunology Justus‐Liebig University Giessen, Campus Kerckhoff Bad Nauheim Germany; 28. Unit of Immunology, Rheumatology, Allergy and Rare Diseases, Inflammation, Fibrosis and Ageing Initiative IRCCS San Raffaele Hospital Milan Italy; 29. University Vita Salute San Raffaele Milan Italy; 30. Inflammation, Fibrosis and Ageing Initiative, Division of Genetics and Cell Biology IRCCS San Raffaele Scientific Institute Milan Italy; 31. Department of Rheumatology, Institut de Recerca Sant Pau Hospital de la Santa Creu i Sant Pau Barcelona Spain; 32. Rheumatology Charité University Hospital Berlin Germany; 33. Department of Internal Medicine and Clinical Immunology, Referral Centre for Rare Systemic Autoimmune Diseases North of France, North‐West, Mediterranean and Guadeloupe Centre Hospitalier Universitaire de Lille, Inserm, U1286 Lille France; 34. Institute for Translational Research in Inflammation Lille FranceShow moreShow less
Source PDF DOI Publisher page
195 days

Differentiation and Pathologic Significance of Tissue‐Resident Memory‐Like CD8 + T Cells in Systemic Lupus Erythematosus

Authors
Yuya Fujita; Kaoru Yamagata; Satoshi Kubo; Ippei Miyagawa; Koshiro Sonomoto; Yurie Satoh‐Kanda; Masanobu Ueno; Shumpei Kosaka; Aya Nawata; Yoshiya Tanaka; Shingo NakayamadaShow moreShow less
Affiliations
1. The First Department of Internal Medicine School of Medicine, University of Occupational and Environmental Health Kitakyushu Japan; 2. Department of Molecular Targeted Therapies School of Medicine, University of Occupational and Environmental Health Kitakyushu Japan; 3. Department of Clinical Nursing School of Health Sciences, University of Occupational and Environmental Health Kitakyushu Japan; 4. Department of Pathology and Oncology University of Occupational and Environmental Health Kitakyushu JapanShow moreShow less
Source PDF DOI Publisher page
212 days

Cluster analysis identifies anti‐synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti‐Synthetase Syndrome project database

Authors
Akira Yoshida; Iazsmin Bauer Ventura; Eduardo Dourado; Giovanni Zanframundo; Sara Faghihi‐Kashani; Aravinthan Loganathan; Daphne Rivero Gallegos; Francisca Bozan; Gianluca Sambataro; Sangmee Sharon Bae; Laure Gallay; Albert Selva‐O'Callaghan; Andrew L. Mammen; Carlomaurizio Montecucco; Chester V. Oddis; David F. Fiorentino; Francesco Bonella; Frederick W. Miller; Ingrid E. Lundberg; Jorge Rojas‐Serrano; Masataka Kuwana; Miguel Angel González‐Gay; Neil McHugh; Tamera J. Corte; Tracy Jennifer Doyle; Vega Jovani; Linda Carli; Pier Paolo Sainaghi; Natsuka Umezawa; Merrilee Needham; Giovanni Cagnotto; Nair Perez‐Gómez; Paola Tomietto; Massimiliano Limonta; Maria Giovanna Danieli; Antonella Notarnicola; José Cifrian‐Martinez; Julia Martinez‐Barrio; Helena Andersson; Yasuhiro Kondoh; Reinhard Edmund Voll; Stylianos Tomaras; Pari Basharat; Farah Tamirou; Paola Parronchi; Matthias Schneider; the CLASS project participating investigators; Lorenzo Cavagna; Rohit AggarwalShow moreShow less
Affiliations
1. Department of Allergy and Rheumatology Nippon Medical School Graduate School of Medicine Tokyo Japan; 2. Section of Rheumatology, Department of Medicine University of Chicago Chicago IL USA; 3. Rheumatology Department, Unidade Local de Saúde da Região de Aveiro Aveiro Portugal; 4. Aveiro Rheumatology Research Centre, Egas Moniz Health Alliance Aveiro Portugal; 5. Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa Lisbon Portugal; 6. Department of Internal Medicine and Therapeutics, Università di Pavia Pavia Italy; 7. Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo Pavia Italy; 8. Division of Rheumatology and Clinical Immunology University of Pittsburgh School of Medicine Pittsburgh PA USA; 9. Royal National Hospital for Rheumatic Diseases Bath UK; 10. Department of Life Sciences University of Bath Bath UK; 11. Arthritis Australia, Broadway, Glebe NSW Australia; 12. Interstitial Lung Disease and Rheumatology Units, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas Mexico City Mexico; 13. Section of Rheumatology, Department of Medicine, Hospital Clínico Universidad de Chile Santiago Chile; 14. Regional Referral Center for Rare Lung Disease, Policlinico "G. Rodolico‐San Marco" University of Catania Catania Italy; 15. Division of Rheumatology, Department of Medicine, David Geffen School of Medicine University of California Los Angeles Los Angeles CA USA; 16. Department of Clinical Immunology, Hôpital Édouard Herriot Lyon France; 17. Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona Barcelona Spain; 18. National Institute of Arthritis and Musculoskeletal and Skin Disorders, National Institutes of Health Bethesda MD USA; 19. Department of Neurology Johns Hopkins University School of Medicine Baltimore MD USA; 20. Department of Dermatology Stanford University School of Medicine Redwood City CA USA; 21. Center for interstitial and rare lung diseases, Pneumology Department, Ruhrlandklinik University Hospital University of Duisburg‐Essen Essen Germany; 22. Environmental Autoimmunity Group, Clinical Research Branch National Institute of Environmental Health Sciences, National Institutes of Health Durham NC USA; 23. Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet Stockholm Sweden; 24. Division of Rheumatology, IIS‐Fundación Jiménez Díaz Madrid Spain; 25. Medicine and Psychiatry Department University of Cantabria Santander Spain; 26. Department of Respiratory Medicine, Royal Prince Alfred Hospital University of Sydney Sydney Australia; 27. Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital Boston MA USA; 28. Department of Rheumatology, Hospital General Universitario Dr. Balmis, ISABIAL Alicante Spain; 29. Rheumatology Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero‐Universitaria Pisana Pisa Italy; 30. Department of Translational Medicine and CAAD (Center for Allergic and Autoimmune Diseases), Università del Piemonte Orientale UPO Novara Italy; 31. Rheumatology and Internal Medicine Division, Azienda Ospedaliero Universitaria Maggiore della Carità di Novara Novara Italy; 32. Department of Rheumatology, Graduate School of Medical and Dental Sciences Institute of Science Tokyo Tokyo Japan; 33. Neuromuscular Clinic Perron Institute for Neurological and Translational Science, QEII Medical Centre Nedlands Western Australia Australia; 34. Department of Neurology, Fiona Stanley Hospital Perth Western Australia Australia; 35. Institute for Immunology and Infectious Diseases Murdoch University Perth Western Australia Australia; 36. School of Medicine University of Notre Dame Perth Western Australia Australia; 37. Rheumatology, Clinical Sciences Malmö Lund University Malmö Sweden; 38. UGC de Reumatología, Complejo Hospitalario Universitario de Vigo Vigo Spain; 39. Internal Medicine Department, Rheumatology Unit, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste Italy; 40. Rheumatology, ASST Papa Giovanni XXIII Bergamo Italy; 41. Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Torrette di Ancona Italy; 42. SOS Immunologia delle Malattie Rare e dei Trapianti, Clinica Medica, AOU delle Marche, Torrette di Ancona Italy; 43. Department of Pulmonology, Hospital Universitario Marqués de Valdecilla, Av Valdecilla SN Santander Spain; 44. Instituto de Investigación Biomédica de Cantabria (IDIVAL), Santander Spain; 45. University of Cantabria Santander Spain; 46. Department of Rheumatology, Hospital Universitario Gregorio Marañón Madrid Spain; 47. Department of Rheumatology Oslo University Hospital Oslo Norway; 48. Department of Respiratory Medicine and Allergology Aichi Medical University Nagakute Japan; 49. Department of Rheumatology and Clinical Immunology Medical Center ‐ University of Freiburg, Faculty of Medicine, University of Freiburg Freiburg Germany; 50. Department of Rheumatology, Helios Clinic Vogelsang‐Gommern Gommern Germany; 51. Department of Medicine, Division of Rheumatology, London Health Sciences Centre, Schulich School of Medicine & Dentistry University of Western Ontario London ON Canada; 52. Department of Rheumatology, Cliniques Universitaires Saint‐Luc, Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, UCLouvain Brussels Belgium; 53. Department of Experimental and Clinical Medicine University of Florence Florence Italy; 54. Department of Rheumatology, Heinrich‐Heine University Düsseldorf Germany; 55. Hiller Research Center for Rheumatology, Heinrich‐Heine University Düsseldorf GermanyShow moreShow less
Source PDF DOI Publisher page
134 days

The Association Between Systemic Inflammation as Measured by Calprotectin and Autoantibody Load in Rheumatoid Arthritis

Authors
Caroline Grönwall; Linda Mathsson Alm; Helga Westerlind; Isabel Gehring; Nasim Ghasemzadeh; Niels Steen Krogh; Siri Lillegraven; Espen Haavardsholm; Martina Johannesson; Tore K. Kvien; Johan Rönnelid; Tue Wenzel Kragstrup; Bente Glintborg; Merete Lund Hetland; Hilde Berner Hammer; Danish Rheumatologic Biobank Study Group; Swedish Rheumatology Quality Register Biobank Study Group; Johan AsklingShow moreShow less
Affiliations
1. Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet Karolinska University Hospital, Center for Molecular Medicine Stockholm Sweden; 2. Thermo Fisher Scientific Uppsala Sweden; 3. Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden; 4. Clinical Epidemiology Division, Department of Medicine Solna Karolinska Institutet Stockholm Sweden; 5. Thermo Fisher Scientific Freiburg Germany; 6. ZiteLab ApS Frederiksberg Denmark; 7. Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY) Diakonhjemmet Hospital Oslo Norway; 8. Faculty of Medicine University of Oslo Oslo Norway; 9. Department of Biomedicine Aarhus University Aarhus Denmark; 10. Department of Rheumatology Silkeborg Regional Hospital Silkeborg Denmark; 11. Department of Molecular Medicine Aarhus University Hospital Aarhus Denmark; 12. Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark; 13. DANBIO, The Danish Rheumatologic Biobank, and Copenhagen Center for Arthritis Research (COPECARE) Center for Rheumatology and Spine Diseases Rigshospitalet Glostrup DenmarkShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Arthritis & Rheumatology take to review a manuscript?

As of 2026-11-17, CrushSCI has 30 complete review records for Arthritis & Rheumatology. The fastest paper went from submission to acceptance in 2 days (Dermatomyositis in skin of color population: expanding clinical recognition, received 2026-06-16, accepted 2026-06-18); the slowest took 345 days. The average is 133.2 days and the median is 133 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.